每经AI快讯，厦钨新能1月27日晚间发布公告称，本次计提减值准备计入资产减值损失和信用减值损失 科目，合计对公司2025年度合并利润总额影响约为2.05亿元。本次计提资产减值损失和信用减值损失数 据未经审计，最终数据以会计师事务所年度审计确认的金额为准。 （记者 曾健辉） 每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 ...

（记者 王晓波） 每经头条（nbdtoutiao）——从极寒测试到万套装车！半固态电池今年有望搭载多款新车：各大厂商摩 拳擦掌，动力电池技术迎来迭代年 每经AI快讯，永安林业1月27日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润亏损7400 万元~1.1亿元，基本每股收益亏损0.33元~0.22元。上年同期归属于上市公司股东的净利润亏损8503.84 万元，基本每股收益亏损0.25元。公司2025年年度业绩预亏的主要原因为生物质能项目计提减值影响。 因生物质能项目停止建设，预计将计提相关资产减值损失，具体减值金额将依据公司聘请的评估机构及 审计机构的评估和审计认定金额为准。 ...

南财智讯1月27日电，天威视讯发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为亏 损16,000.00万元—22,000.00万元，预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为 亏损18,400.00万元—24,400.00万元；公司预计2025年利润总额、归属于上市公司股东的净利润、归属于 上市公司股东的扣除非经常性损益的净利润亏损主要原因：一是受市场环境变化、行业竞争加剧等因素 影响，广深及周边地区通用数据中心机柜租赁价格持续下行，虽然公司市场团队多方努力，但深汕威视 数据中心（一期）以及南山、龙华数据中心销售仍未达预期，根据《企业会计准则第8号一资产减 值》，基于谨慎性原则，公司对上述三个数据中心资产拟计提减值，最终资产减值准备实际计提金额以 评估机构的评估报告及会计师事务所审计数据为准；二是受用户消费习惯、市场变化等影响，公司传统 有线电视、宽带业务收入等出现下降；三是对合同资产计提减值准备，以及与收益相关的政府补助较上 年同期减少。 ...

Core Viewpoint - The company is undergoing a review of its projects and operations for the fiscal year ending 2025, revealing impairment indicators primarily related to the Kinsevere operation, which may negatively impact its unaudited profit for that year [1] Group 1: Impairment Indicators - The review indicates several impairment signs for the Kinsevere operation, including sales restrictions on cobalt in the Democratic Republic of Congo, leading to the cobalt processing plant being in maintenance mode [1] - Challenges related to electricity supply are affecting the daily operations and capacity enhancement of expansion projects [1] - Financial uncertainties, including additional tax rates and the deductibility of value-added tax, are also contributing to the impairment indicators [1] Group 2: Financial Impact - The board anticipates that the unaudited profit for the fiscal year 2025 may be negatively impacted by an impairment charge estimated between $280 million and $300 million before tax [1] - After accounting for the impairment, the company expects to achieve an unaudited net profit attributable to equity holders of approximately $500 million to $520 million for the year ending December 31, 2025 [1] - The impairment is characterized as an accounting adjustment and a non-cash item, thus not affecting the company's cash flow [1] Group 3: Operational Performance - The significant unaudited profit is attributed to the strong operational performance of the Las Bambas and Dugald River mines, along with the positive impact of rising copper and precious metal prices [2] - However, operational challenges and financial transactions, including power supply issues at the Kinsevere mine and ongoing cobalt export restrictions, have negatively impacted the company's performance [2] - The fiscal year 2025 is also expected to experience hedging losses, further complicating the financial outlook [2]

Core Viewpoint - The company is undergoing a review of the recoverable amounts of its projects and operations, indicating potential impairment related to the Kinsevere operation, which may negatively impact the unaudited profit for the fiscal year 2025 by approximately $280 million to $300 million before tax [1] Group 1: Financial Performance - The company expects to achieve an unaudited net profit attributable to equity holders of approximately $500 million to $520 million for the fiscal year ending December 31, 2025, after accounting for the impairment [1] - The significant profit is attributed to the strong operational performance of the Las Bambas and Dugald River mines, along with the positive impact of rising copper and precious metal prices [2] Group 2: Operational Challenges - The Kinsevere operation faces several impairment indicators, including sales restrictions on cobalt in the Democratic Republic of the Congo, which has led to the cobalt processing plant being in maintenance mode [1] - Power supply challenges are affecting the daily operations and capacity enhancement processes of the expansion project at Kinsevere [1] - Ongoing operational challenges and financial transactions, including hedging losses for the fiscal year 2025, are also negatively impacting the company's performance [2]

Group 1 - The company expects a net profit attributable to shareholders of between -32 million and -22.5 million yuan for 2025, with a net profit excluding non-recurring gains and losses estimated at -30.5 million to -21.5 million yuan [1] - The company is focusing on "strategic breakthroughs, product leadership, global operations, and organizational drive" to enhance product quality internally and expand market presence externally, leading to a certain degree of revenue growth [1] - 2025 is designated as a strategic layout year for the company's sawing business segment, with plans to establish a sales subsidiary in Germany, advance the Thailand base project, and launch new projects including circular saw blades and alloy steel belts, which will incur additional costs affecting profit [1] Group 2 - The company has actively adjusted its power supply business strategy through organizational changes, operational optimization, and cost reduction, resulting in lower operational costs [2] - The revenue from the consumer electronics power supply business has declined due to intensified competition and adjustments in customer order structures [2] - The photovoltaic new energy sector remains sluggish, leading to price pressures on products, prompting the company to adjust the order structure of its high-power power supply business, which has also seen a decline in revenue [2] - The company plans to conduct impairment tests on goodwill and certain long-term assets of subsidiaries, which is expected to impact net profit by 85 million to 94 million yuan [2]

Core Viewpoint - Bluefeng Biochemical (002513.SZ) expects a net profit loss attributable to shareholders of the listed company between 230 million and 150 million yuan for the year 2025, with a similar range for net profit after deducting non-recurring gains and losses [1] Group 1: Performance Forecast - The company anticipates a net profit loss of 230 million to 150 million yuan for the year 2025 [1] - The expected loss after deducting non-recurring gains and losses is also projected to be between 230 million and 150 million yuan [1] Group 2: Reasons for Performance Changes - The company and its subsidiaries conducted a comprehensive review of various assets at the end of the reporting period, leading to the recognition of asset impairment provisions due to signs of impairment, which reduced the net profit attributable to shareholders by approximately 64.16 million yuan [1] - The agricultural chemical segment continues to incur losses due to a significant increase in raw material prices while the sales prices of main products have been declining [1] - Although the new energy segment has reduced production costs through technological upgrades, it still faces low product prices due to industry competition, resulting in a significant decrease in the loss margin year-on-year, but the profitability has not met expectations [1]

Core Viewpoint - Strongly New Materials (300429.SZ) expects a loss of 100 million to 142 million yuan in 2025, a decrease from the previous year's loss of 181.693 million yuan, indicating an improvement in financial performance despite ongoing challenges [1] Financial Performance - The company reported a loss for the current reporting period, but the loss has decreased compared to the previous year [1] - The expected non-recurring gains and losses will impact net profit by approximately 5.5 million to 8 million yuan [1] Factors Influencing Performance - Market demand and competitive environment have led to a recovery in gross profit during the reporting period [1] - Research and development expenses have increased during the current reporting period [1] - The company plans to recognize inventory impairment losses of 27.3 million yuan and non-current asset impairment losses of 51.2 million yuan [1]

Core Viewpoint - The company Strongly New Materials expects a net profit loss of 100 million to 142 million yuan for the fiscal year 2025, indicating a decrease in losses compared to the previous year [1] Group 1: Financial Performance - The company experienced a loss during the reporting period, but the loss has decreased compared to the previous year [1] - The gross profit has shown some recovery due to market demand and competitive environment [1] - The company plans to recognize an inventory impairment loss of 27.3 million yuan and a non-current asset impairment loss of 51.2 million yuan [1] Group 2: R&D and Non-Recurring Items - Research and development expenses have increased during the reporting period [1] - The expected impact of non-recurring gains and losses on net profit is estimated to be between 5.5 million and 8 million yuan [1]

此外，公司部分控股子公司的经营状况未能得到有效改善，持续出现亏损。同时，受产线开工率不足、 产品市场价格下行等多重不利因素影响，相关资产出现明显的减值迹象。公司基于谨慎性原则，已对存 在减值迹象的资产计提了相应的减值准备，最终减值金额将由聘请的评估机构及会计师事务所进行专业 评估和审计后确定。 （广济药业公告） 近日，广济药业（000952）发布公告称，预计2025年度归母净利润约亏损5.18亿元至3.99亿元。 公司表示，报告期内受行业市场竞争持续加剧影响，主要产品销售价格长期处于低位，导致产能利用率 及整体经营业绩未达预期，仍处于经营性亏损状态。 ...